Literature DB >> 11388537

Efficacy of propofol to prevent bronchoconstriction: effects of preservative.

R H Brown1, R S Greenberg, E M Wagner.   

Abstract

BACKGROUND: The authors previously showed that propofol attenuates bronchoconstriction. Recently, a newer formulation of propofol with metabisulfite preservative has been introduced. metabisulfite causes airway narrowing in asthmatics. Therefore, we tested whether the preservative metabisulfite abolishes the ability of propofol to attenuate bronchoconstriction. The authors used a sheep model in which anesthetic agents could be directly administered to the airways via the bronchial artery.
METHODS: After Internal Review Board approval, seven sheep were anesthetized (pentobarbital 20 mg x kg(-1) x h(-1)) and paralyzed (pancuronium 2 mg), and the lungs were ventilated. After left thoracotomy, the bronchial artery was cannulated and perfused. In random order, propofol with and without metabisulfite, lidocaine (5 mg/ml), or metabisulfite alone (0.125 mg/ml) was infused into the bronchial artery at a rate of 0.06, 0.2, or 0.6 ml/min. After 10 min, airway resistance (Raw) was measured before and after vagal nerve stimulation (30 Hz, 30-ms duration at 30 V for 9 s.) and methacholine challenge (2 microg/ml at 2 ml/min in the bronchial artery). Data were expressed as a percent of maximal response and analyzed by analysis of variance with correction and with significance accepted at P < or = 0.05.
RESULTS: Raw at baseline was not significantly different among the four drugs (P = 0.87). Infusion of lidocaine and propofol without metabisulfite into the bronchial artery caused a dose-dependent attenuation of the vagal nerve stimulation-induced bronchoconstriction (P = 0.001). Propofol with metabisulfite had no effect on vagal nerve stimulation-induced bronchoconstriction (P = 0.40). There was a significant difference in the ability of propofol without metabisulfite compared with propofol with metabisulfite to attenuate vagal nerve stimulation-induced (P = 0.0001) and methacholine-induced bronchoconstriction (P = 0.0001).
CONCLUSION: Propofol without metabisulfite and lidocaine attenuated vagal nerve stimulation-induced bronchoconstriction in a dose-dependent fashion. Propofol without metabisulfite also decreased direct airway smooth muscle constriction. The preservative used for propofol can have a dramatic effect on its ability to attenuate bronchoconstriction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388537     DOI: 10.1097/00000542-200105000-00024

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  Propofol preferentially relaxes neurokinin receptor-2-induced airway smooth muscle contraction in guinea pig trachea.

Authors:  Neil R Gleason; George Gallos; Yi Zhang; Charles W Emala
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

2.  Caveolae and propofol effects on airway smooth muscle.

Authors:  K J Grim; A J Abcejo; A Barnes; V Sathish; D F Smelter; G C Ford; M A Thompson; Y S Prakash; C M Pabelick
Journal:  Br J Anaesth       Date:  2012-04-27       Impact factor: 9.166

3.  Update on perioperative management of the child with asthma.

Authors:  Francesco Dones; Grazia Foresta; Vincenzo Russotto
Journal:  Pediatr Rep       Date:  2012-04-05

4.  Comparative effects of dexmedetomidine and propofol on brain and lung damage in experimental acute ischemic stroke.

Authors:  Patricia R M Rocco; Pedro L Silva; Giselle C Sousa; Marcos Vinicius Fernandes; Fernanda F Cruz; Mariana A Antunes; Carla M da Silva; Christina Takyia; Denise Battaglini; Cynthia S Samary; Chiara Robba; Paolo Pelosi
Journal:  Sci Rep       Date:  2021-11-30       Impact factor: 4.379

5.  Can low dose of propofol effectively suppress fentanyl-induced cough during induction of anaesthesia? A double blind randomized controlled trial.

Authors:  Abolfazl Firouzian; Seyed Abdollah Emadi; Afshin Gholipour Baradari; Robabeh Mousavi; Alieh Zamani Kiasari
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.